Background: Robot-assisted ureteral reimplantation (RAUR) is a relatively new minimally invasive procedure. As such, research is lacking, and the largest adult cohort studies include fewer than 30 patients. Our aim was to be the first population-based study to report on national utilization trends, factors associated with patient selection, inpatient outcomes, and the relative cost of RAUR for adults with benign ureteral disease (BUD).

中文翻译：

---

医院所有权、地理区域、患者年龄、合并症和保险状况似乎会影响患者选择机器人辅助输尿管再植治疗良性疾病：基于人群的分析

背景：机器人辅助输尿管再植术（RAUR）是一种相对较新的微创手术。因此，缺乏研究，最大的成人队列研究包括不到 30 名患者。我们的目标是成为第一个以人群为基础的研究，报告国家使用趋势、与患者选择相关的因素、住院患者结局以及 RAUR 对成人良性输尿管疾病 (BUD) 的相对成本。